Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    15486323 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Niacin to Improve Blood Flow in People With Sickle Cell Disease
Condition: Sickle Cell Disease
Interventions: Drug: Niacin-ER;   Drug: Placebo;   Drug: L-NMMA;   Drug: Acetylcholine

Indicates status has not been verified in more than two years